[go: up one dir, main page]

IT1303735B1 - Acidi ialuronici reticolati e loro usi medici. - Google Patents

Acidi ialuronici reticolati e loro usi medici.

Info

Publication number
IT1303735B1
IT1303735B1 IT1998MI002440A ITMI982440A IT1303735B1 IT 1303735 B1 IT1303735 B1 IT 1303735B1 IT 1998MI002440 A IT1998MI002440 A IT 1998MI002440A IT MI982440 A ITMI982440 A IT MI982440A IT 1303735 B1 IT1303735 B1 IT 1303735B1
Authority
IT
Italy
Prior art keywords
cross
linked hyaluronic
hyaluronic acids
medical uses
linked
Prior art date
Application number
IT1998MI002440A
Other languages
English (en)
Inventor
Rolando Barbucci
Roberto Rapuoli
Original Assignee
Falorni Italia Farmaceutici S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11381033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1303735(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falorni Italia Farmaceutici S filed Critical Falorni Italia Farmaceutici S
Priority to IT1998MI002440A priority Critical patent/IT1303735B1/it
Priority to EP99968778A priority patent/EP1144459B2/en
Priority to US09/830,761 priority patent/US6831172B1/en
Priority to DE69903351T priority patent/DE69903351T3/de
Priority to CA002350667A priority patent/CA2350667A1/en
Priority to CN99813143A priority patent/CN1131241C/zh
Priority to TR2001/01324T priority patent/TR200101324T2/xx
Priority to CZ20011650A priority patent/CZ296842B6/cs
Priority to HU0104296A priority patent/HU229668B1/hu
Priority to HK02102744.3A priority patent/HK1041011B/zh
Priority to PCT/EP1999/008481 priority patent/WO2000027887A2/en
Priority to KR1020017005929A priority patent/KR100674177B1/ko
Priority to ES99968778T priority patent/ES2184521T5/es
Priority to PT99968778T priority patent/PT1144459E/pt
Priority to JP2000581064A priority patent/JP2002529550A/ja
Priority to NZ511306A priority patent/NZ511306A/en
Priority to AT99968778T priority patent/ATE225371T1/de
Priority to AU26600/00A priority patent/AU757102B2/en
Priority to BR9915235-5A priority patent/BR9915235A/pt
Priority to RU2001112488/04A priority patent/RU2230752C2/ru
Priority to IL14306399A priority patent/IL143063A0/xx
Priority to DK99968778.3T priority patent/DK1144459T4/da
Publication of ITMI982440A1 publication Critical patent/ITMI982440A1/it
Publication of IT1303735B1 publication Critical patent/IT1303735B1/it
Application granted granted Critical
Priority to NO20012315A priority patent/NO20012315L/no
Priority to ZA200103799A priority patent/ZA200103799B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IT1998MI002440A 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici. IT1303735B1 (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.
ES99968778T ES2184521T5 (es) 1998-11-11 1999-11-08 Ácidos hialurónicos reticulados y sus usos médicos.
JP2000581064A JP2002529550A (ja) 1998-11-11 1999-11-08 架橋ヒアルロン酸及びその医療上の使用
DE69903351T DE69903351T3 (de) 1998-11-11 1999-11-08 Vernetzte hyaluronsäure und ihre medizinischen verwendungen
CA002350667A CA2350667A1 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
CN99813143A CN1131241C (zh) 1998-11-11 1999-11-08 交联的透明质酸和它在医药方面的应用
TR2001/01324T TR200101324T2 (tr) 1998-11-11 1999-11-08 Çapraz bağlanmış hialuronik asitler ve bunların tıbbi kullanımları
CZ20011650A CZ296842B6 (cs) 1998-11-11 1999-11-08 Zesítené hyaluronové kyseliny
HU0104296A HU229668B1 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids, uses thereof and biological substances containing them
HK02102744.3A HK1041011B (zh) 1998-11-11 1999-11-08 交聯的透明質酸和它在醫藥方面的應用
PCT/EP1999/008481 WO2000027887A2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
KR1020017005929A KR100674177B1 (ko) 1998-11-11 1999-11-08 교차 결합된 히알루론산과 그것의 의학적 용도
EP99968778A EP1144459B2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
PT99968778T PT1144459E (pt) 1998-11-11 1999-11-08 Acidos hialuronicos reticulados e as suas utilizacoes em medicina
US09/830,761 US6831172B1 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
NZ511306A NZ511306A (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids obtained by reaction of activated carboxy groups of hyaluronic acid (HY) with a polyamine
AT99968778T ATE225371T1 (de) 1998-11-11 1999-11-08 Vernetzte hyaluronsäure und ihre medizinischen verwendungen
AU26600/00A AU757102B2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
BR9915235-5A BR9915235A (pt) 1998-11-11 1999-11-08 ácidos hialurÈnicos reticulados e usos médicos dos mesmos
RU2001112488/04A RU2230752C2 (ru) 1998-11-11 1999-11-08 Поперечносшитые гиалуроновые кислоты и их применение в медицине
IL14306399A IL143063A0 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
DK99968778.3T DK1144459T4 (da) 1998-11-11 1999-11-08 Tværbundne hyaluronsyrer og medicinske anvendelser deraf
NO20012315A NO20012315L (no) 1998-11-11 2001-05-10 Fornettede hyaluronsyrer og medisinske anvendelser derav
ZA200103799A ZA200103799B (en) 1998-11-11 2001-05-10 Cross-linked hyaluronic acids and medical uses thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.

Publications (2)

Publication Number Publication Date
ITMI982440A1 ITMI982440A1 (it) 2000-05-11
IT1303735B1 true IT1303735B1 (it) 2001-02-23

Family

ID=11381033

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.

Country Status (24)

Country Link
US (1) US6831172B1 (it)
EP (1) EP1144459B2 (it)
JP (1) JP2002529550A (it)
KR (1) KR100674177B1 (it)
CN (1) CN1131241C (it)
AT (1) ATE225371T1 (it)
AU (1) AU757102B2 (it)
BR (1) BR9915235A (it)
CA (1) CA2350667A1 (it)
CZ (1) CZ296842B6 (it)
DE (1) DE69903351T3 (it)
DK (1) DK1144459T4 (it)
ES (1) ES2184521T5 (it)
HK (1) HK1041011B (it)
HU (1) HU229668B1 (it)
IL (1) IL143063A0 (it)
IT (1) IT1303735B1 (it)
NO (1) NO20012315L (it)
NZ (1) NZ511306A (it)
PT (1) PT1144459E (it)
RU (1) RU2230752C2 (it)
TR (1) TR200101324T2 (it)
WO (1) WO2000027887A2 (it)
ZA (1) ZA200103799B (it)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD980037A1 (it) * 1998-02-25 1999-08-25 Fidia Advanced Biopolymers Srl Acido ialuronico solfatato e i suoi derivati legati covalentemente a polimeri sintetici pe la preparazione di biomateriali e per il rivesti
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US7068729B2 (en) 2001-12-21 2006-06-27 Digital Fountain, Inc. Multi-stage code generator and decoder for communication systems
US6307487B1 (en) 1998-09-23 2001-10-23 Digital Fountain, Inc. Information additive code generator and decoder for communication systems
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
ATE376824T1 (de) 1999-01-13 2007-11-15 Alchemia Oncology Pty Ltd Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
KR100338179B1 (ko) * 2000-05-08 2002-05-24 김범철 안질환 치료용 약물 전달을 위한 그래프트 중합체 및 그제조방법
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
KR100375299B1 (ko) * 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
WO2002056904A1 (en) * 2001-01-16 2002-07-25 The Regents Of The University Of Michigan Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
US7335383B2 (en) 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
CN1578677A (zh) * 2001-08-27 2005-02-09 美迪泰克研究有限公司 改良的治疗方案
US9240810B2 (en) 2002-06-11 2016-01-19 Digital Fountain, Inc. Systems and processes for decoding chain reaction codes through inactivation
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
AU2003277198A1 (en) 2002-10-05 2004-05-04 Digital Fountain, Inc. Systematic encoding and decoding of chain reaction codes
EP1560543A2 (en) * 2002-10-25 2005-08-10 Essentia Biosystems, Inc. Implantable medical devices using zinc
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
EP1595892A4 (en) 2003-02-21 2007-06-20 Terumo Corp NETWORKABLE POLYSACCHARIDE DERIVATIVE, PRODUCTION PROCESS THEREFOR, COMPOSIBLE POLYSACCHARID DERIVATIVE COMPOSITION, AND MATERIAL FOR MEDICAL TREATMENT
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
EP1610838A1 (en) * 2003-04-04 2006-01-04 Bayco Tech Limited Vascular stent
CN101834610B (zh) 2003-10-06 2013-01-30 数字方敦股份有限公司 通过通信信道接收从源发射的数据的方法和装置
ES2406555T3 (es) * 2003-10-29 2013-06-07 Teijin Limited Compuesto de ácido hialurónico, hidrogel del mismo y material para tratar articulaciones
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
KR101205758B1 (ko) 2004-05-07 2012-12-03 디지털 파운튼, 인크. 파일 다운로드 및 스트리밍 시스템
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
JP5060131B2 (ja) * 2004-09-07 2012-10-31 中外製薬株式会社 水溶性ヒアルロン酸修飾物の製造方法
EP1818344A4 (en) * 2004-11-15 2012-04-18 Shiseido Co Ltd METHOD FOR SYNTHESIZING RETICULATED HYALURONIC ACID GEL
US8481080B2 (en) * 2004-11-24 2013-07-09 Novozymes Biopolymer A/S Method of cross-linking hyaluronic acid with divinulsulfone
CN101133102A (zh) * 2004-12-30 2008-02-27 诺维信生物聚合物公司 与α-羟酸的聚合物连接的透明质酸
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
TW200643033A (en) * 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
US7676735B2 (en) 2005-06-10 2010-03-09 Digital Fountain Inc. Forward error-correcting (FEC) coding and streaming
WO2007012133A1 (en) 2005-07-27 2007-02-01 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
MY149606A (en) 2005-09-07 2013-09-13 Alchemia Oncology Pty Ltd Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
US7879818B2 (en) * 2005-12-23 2011-02-01 Janos Borbely Hyaluronic acid-based cross-linked nanoparticles
KR100737954B1 (ko) * 2006-01-03 2007-07-13 고려대학교 산학협력단 조직재생을 위한 히알루론산-기초된 주사형 하이드로겔
WO2007095550A2 (en) 2006-02-13 2007-08-23 Digital Fountain, Inc. Streaming and buffering using variable fec overhead and protection periods
US9270414B2 (en) 2006-02-21 2016-02-23 Digital Fountain, Inc. Multiple-field based code generator and decoder for communications systems
US20100273734A1 (en) * 2006-02-28 2010-10-28 Novozymes Biopolymer A/S Derivatives of Hyaluronic Acids
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
US7971129B2 (en) 2006-05-10 2011-06-28 Digital Fountain, Inc. Code generator and decoder for communications systems operating using hybrid codes to allow for multiple efficient users of the communications systems
US9178535B2 (en) 2006-06-09 2015-11-03 Digital Fountain, Inc. Dynamic stream interleaving and sub-stream based delivery
US9380096B2 (en) 2006-06-09 2016-06-28 Qualcomm Incorporated Enhanced block-request streaming system for handling low-latency streaming
US9386064B2 (en) 2006-06-09 2016-07-05 Qualcomm Incorporated Enhanced block-request streaming using URL templates and construction rules
US9209934B2 (en) 2006-06-09 2015-12-08 Qualcomm Incorporated Enhanced block-request streaming using cooperative parallel HTTP and forward error correction
US9432433B2 (en) 2006-06-09 2016-08-30 Qualcomm Incorporated Enhanced block-request streaming system using signaling or block creation
US9419749B2 (en) 2009-08-19 2016-08-16 Qualcomm Incorporated Methods and apparatus employing FEC codes with permanent inactivation of symbols for encoding and decoding processes
EP2049572A1 (en) * 2006-08-04 2009-04-22 Novozymes Biopolymer A/S Branched hyaluronic acid and method of manufacture
US20080070993A1 (en) * 2006-09-07 2008-03-20 Janos Borbely Additives for cosmetic products and the like
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
US20090023631A1 (en) * 2007-07-18 2009-01-22 Lorenc Z Paul Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery
EP2178908B1 (en) * 2007-08-15 2013-07-10 Metamorefix Peptides and pharmaceutical compositions for treating connective tissue
KR101129260B1 (ko) 2007-09-12 2012-03-27 디지털 파운튼, 인크. 신뢰성 있는 통신들을 가능하게 하는 소스 식별 정보 생성 및 통신
KR101594552B1 (ko) 2008-04-04 2016-02-17 유니버시티 오브 유타 리서치 파운데이션 알킬화된 반합성 글리코사미노글리코산 에테르 및 이의 제조 및 사용 방법
WO2009148985A2 (en) * 2008-06-03 2009-12-10 E. I. Du Pont De Nemours And Company A tissue coating for preventing undesired tissue-to-tissue adhesions
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
KR20110042340A (ko) * 2008-08-05 2011-04-26 데이진 가부시키가이샤 하이드로겔
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
US9281847B2 (en) 2009-02-27 2016-03-08 Qualcomm Incorporated Mobile reception of digital video broadcasting—terrestrial services
US9288010B2 (en) 2009-08-19 2016-03-15 Qualcomm Incorporated Universal file delivery methods for providing unequal error protection and bundled file delivery services
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US9917874B2 (en) 2009-09-22 2018-03-13 Qualcomm Incorporated Enhanced block-request streaming using block partitioning or request controls for improved client-side handling
JP5604072B2 (ja) * 2009-09-28 2014-10-08 テルモ株式会社 活性エステル化多糖およびその製造方法
FR2954945B1 (fr) * 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
US9225961B2 (en) 2010-05-13 2015-12-29 Qualcomm Incorporated Frame packing for asymmetric stereo video
KR101400907B1 (ko) * 2010-07-12 2014-06-10 포항공과대학교 산학협력단 조직 증강용 충전 조성물
US9596447B2 (en) 2010-07-21 2017-03-14 Qualcomm Incorporated Providing frame packing type information for video coding
US9319448B2 (en) 2010-08-10 2016-04-19 Qualcomm Incorporated Trick modes for network streaming of coded multimedia data
US9270299B2 (en) 2011-02-11 2016-02-23 Qualcomm Incorporated Encoding and decoding using elastic codes with flexible source block mapping
US8958375B2 (en) 2011-02-11 2015-02-17 Qualcomm Incorporated Framing for an improved radio link protocol including FEC
AU2012230822A1 (en) 2011-03-23 2013-11-07 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции
US9253233B2 (en) 2011-08-31 2016-02-02 Qualcomm Incorporated Switch signaling methods providing improved switching between representations for adaptive HTTP streaming
US9843844B2 (en) 2011-10-05 2017-12-12 Qualcomm Incorporated Network streaming of media data
CZ2012136A3 (cs) * 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
US9294226B2 (en) 2012-03-26 2016-03-22 Qualcomm Incorporated Universal object delivery and template-based file delivery
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
FR3005056B1 (fr) * 2013-04-24 2016-04-01 Ayawane Hydrogel a base de polysaccharides natifs et/ou fonctionnalises, phosphates co-reticules
CN105473623B (zh) 2013-06-28 2019-10-29 盖尔德玛公司 用于制备交联的透明质酸产物的方法
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
ITUD20130119A1 (it) * 2013-09-12 2015-03-13 Limacorporate Spa Idrogel biocompatibile per uso biomedico o farmaceutico, polimero intermedio per realizzare detto idrogel biocompatibile e relativo metodo di realizzazione
US20150141910A1 (en) * 2013-11-14 2015-05-21 University Medical Pharmaceuticals Corporation Microneedles for therapeutic agent delivery with improved mechanical properties
ES2811269T3 (es) 2014-01-31 2021-03-11 Seikagaku Kogyo Co Ltd Agente de reticulación de diamina, cuerpo reticulado de polisacárido ácido y material médico
CN116284867A (zh) 2015-12-29 2023-06-23 高德美控股有限公司 用于生物聚合物的脱乙酰化的方法
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CA3037651A1 (en) 2016-09-21 2018-03-29 Nestle Skin Health Sa Hyaluronic acid gel with a divalent zinc cation
JP7216006B2 (ja) 2017-03-22 2023-01-31 ジェネンテック， インコーポレイテッド ヒドロゲル架橋ヒアルロン酸プロドラッグ組成物及び方法
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Hyaluronic acid gel with a divalent cation
CN107469090B (zh) * 2017-08-15 2020-05-12 浙江大学 可共载抗肿瘤药物和核酸药物的纳米载体及抗肿瘤药物纳米制剂
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
EP3659632A1 (en) 2018-11-29 2020-06-03 Nestlé Skin Health SA Post-crosslinking partial degradation of amide crosslinked hydrogels
WO2020212920A1 (en) * 2019-04-19 2020-10-22 Jointherapeutics Srl Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
CN110123741B (zh) * 2019-06-24 2022-02-08 中国医学科学院基础医学研究所 一种铁交联透明质酸纳米凝胶、其制备方法以及用途
CN110684211B (zh) * 2019-10-14 2022-07-12 宁夏妙朗生物科技有限公司 制备抵抗α-葡萄糖苷酶水解的交联右旋糖苷凝胶的方法
EP4069753A1 (en) 2019-12-02 2022-10-12 Galderma Holding SA High molecular weight esthetic compositions
WO2022109050A1 (en) * 2020-11-18 2022-05-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds
EP4247340A4 (en) 2020-11-18 2024-10-02 Bexson Biomedical, Inc. COMPLEXING SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS
EP4473021A1 (en) 2022-02-01 2024-12-11 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
CN114561046B (zh) * 2022-02-28 2023-10-27 江南大学 一种胍基透明质酸型抗菌水凝胶及其制备方法和应用
US20260028458A1 (en) 2024-07-24 2026-01-29 Galderma Holding SA High-durability glycosaminoglycan gels and methods of making the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
RU2113221C1 (ru) * 1990-05-04 1998-06-20 Ииссум Рисерч Дивелопмент Компани оф дзе Хебрю Юниверсити оф Иеруcалим Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы
RU2017751C1 (ru) * 1991-05-22 1994-08-15 Институт пищевых веществ РАН Способ получения гиалуроновой кислоты
ATE193654T1 (de) * 1991-08-16 2000-06-15 Miles A Galin Mit arzneimittel überzogenes lichtbrechendes implantat für die vordere augenkammer
IT1254170B (it) * 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
CA2076732C (en) * 1992-04-17 2006-05-09 Kimberly-Clark Worldwide, Inc. Modified polysaccharides having improved absorbent properties and process for the preparation thereof
JPH06154596A (ja) * 1992-11-18 1994-06-03 Sanyo Chem Ind Ltd 耐塩安定性吸収剤及びその製法
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
JPH0959303A (ja) * 1995-08-22 1997-03-04 Shiseido Co Ltd 生体適合性ヒアルロン酸ゲル及びその用途
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.

Also Published As

Publication number Publication date
NO20012315D0 (no) 2001-05-10
EP1144459B1 (en) 2002-10-02
WO2000027887A3 (en) 2000-11-16
HUP0104296A2 (hu) 2002-03-28
HK1041011B (zh) 2004-10-08
AU757102B2 (en) 2003-01-30
HU229668B1 (en) 2014-04-28
EP1144459A2 (en) 2001-10-17
CA2350667A1 (en) 2000-05-18
HUP0104296A3 (en) 2003-12-29
DK1144459T3 (da) 2003-02-03
KR100674177B1 (ko) 2007-01-24
CN1328573A (zh) 2001-12-26
ES2184521T3 (es) 2003-04-01
WO2000027887A2 (en) 2000-05-18
HK1041011A1 (en) 2002-06-28
NZ511306A (en) 2003-05-30
AU2660000A (en) 2000-05-29
DE69903351D1 (de) 2002-11-07
DE69903351T3 (de) 2012-02-09
DK1144459T4 (da) 2011-06-06
CN1131241C (zh) 2003-12-17
IL143063A0 (en) 2002-04-21
PT1144459E (pt) 2003-01-31
EP1144459B2 (en) 2011-02-23
ES2184521T5 (es) 2011-06-13
ZA200103799B (en) 2002-08-12
DE69903351T2 (de) 2003-07-03
BR9915235A (pt) 2001-07-24
RU2230752C2 (ru) 2004-06-20
CZ296842B6 (cs) 2006-06-14
US6831172B1 (en) 2004-12-14
CZ20011650A3 (cs) 2001-09-12
ITMI982440A1 (it) 2000-05-11
KR20010101001A (ko) 2001-11-14
TR200101324T2 (tr) 2001-09-21
JP2002529550A (ja) 2002-09-10
ATE225371T1 (de) 2002-10-15
NO20012315L (no) 2001-07-06

Similar Documents

Publication Publication Date Title
IT1303735B1 (it) Acidi ialuronici reticolati e loro usi medici.
BR9508031A (pt) Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto
EE200200130A (et) Uued farmatseutiliste omadustega aminodikarboksüülhappe derivaadid
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
TR199800849T2 (xx) Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
DE60012176D1 (de) Polymerisation von fluoropolymeren
HUP0004230A2 (hu) Probucol monoésztereinek alkalmazása VCAM-1 gátlására alkalmas gyógyászati készítmények előállítására
ID29399A (id) Proses polimerisasi
DK1240172T3 (da) Nye aminopropylphosphinsyrer
BRPI0413449A (pt) compostos de quinoxalina
EP1392293A4 (en) METHOD FOR THE TREATMENT OF TUMORS WITH NORDIHYDROGUAIARETINIC ACID DERIVATIVES
AU2003273466A1 (en) Polyamino acids functionalized by at least one hydrophobic group and the therapeutic applications thereof
HUP0203914A2 (en) High order nucleic acid based structures
ITRM20020014A1 (it) Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del
EP1164156A4 (en) METHOD FOR THE POLYMERIZATION OF SILALKYLENE SILOXANES
FI970679A7 (fi) Hydroksialkaanihapoista muodostettujen polymeerien valmistus
AU3524800A (en) Polycyclic polymers containing pendant cyclic anhydride groups
FR2794757B1 (fr) Procede de polymerisation de l'isobutene
IT1229482B (it) Acidi (rs) 2 (2,3 diidro 5 idrossi 4,6,7 trimetilbenzofuranil) acetico e 2 (2,3 diidro 5 acilossi 4,6,7 trimetilbenzofuranil) acetici e loro esteri, utili come farmaci mucoregolatori ed antiischemici.
IT1312536B1 (it) Procedimento per la produzione e purificazione di acidi aromatici.
TR199600583A2 (tr) Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.
ITTO930519A1 (it) Procedimento di sintesi di acidi cloroacetici.
IT1307223B1 (it) Catalizzatore per la polimerizzazione di alfa-olefine e procedimentoper la produzione di un polimero alfa-olefinico.
ATE270551T1 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol
IT1319169B1 (it) Procedimento per la purificazione di acidi carbossilici aromatici.